Publicaciones en las que colabora con Salvador Resino García (16)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2003

  1. CD8+ T-cell numbers predict the response to antiviral therapy in HIV-1-infected children

    Pediatric Research, Vol. 53, Núm. 2, pp. 309-312

  2. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

    Pediatrics, Vol. 111, Núm. 2

  3. Neuroprotective effects of early antiretrovirals in vertical HIV infection

    Pediatric Neurology, Vol. 29, Núm. 3, pp. 218-221

  4. Reconstitución clínica e inmunológica completa tras el tratamiento antirretroviral de gran actividad en un niño infectado verticalmente por el virus de la inmunodeficiencia humana tipo 1 con enfermedad avanzada

    Medicina Clinica, Vol. 120, Núm. 11, pp. 417-420

  5. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers

    Clinical and Experimental Immunology, Vol. 131, Núm. 1, pp. 130-137

2002

  1. Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS

    AIDS Research and Human Retroviruses, Vol. 18, Núm. 18, pp. 1395-1406

  2. Immunological recovery after 3 years' antiretroviral therapy in HIV-1-infected children

    AIDS, Vol. 16, Núm. 3, pp. 483-486

  3. Impact of antiretroviral protocols on dynamics of AIDS progression markers

    Archives of Disease in Childhood, Vol. 86, Núm. 2, pp. 119-124

2001

  1. Factor de necrosis tumoral (TNF-α) en el diagnóstico de meningitis neonatal bacteriana o aséptica

    Acta Pediatrica Espanola, Vol. 59, Núm. 7, pp. 374-378

  2. Impaired interleukin-5 (IL-5) production by T cells as a prognostic marker of disease progression in human immunodeficiency virus type 1 (HIV-1)-infected children

    European Cytokine Network, Vol. 12, Núm. 2, pp. 253-259

2000

  1. Clinical relevance of cytokine production in HIV-1 infection in children on antiretroviral therapy

    Scandinavian Journal of Immunology, Vol. 52, Núm. 6, pp. 634-640

1999

  1. Correlation of viral load and CD8 T-lymphocytes with development of neurological manifestations in vertically HIV-1-lnfected infants. A prospective longitudinal study

    Neuropediatrics, Vol. 30, Núm. 4, pp. 197-204

  2. Prognostic markers in naive infants younger than two months of age with HIV-1 infection

    Pediatrics and Related Topics, Vol. 38, Núm. 5-6, pp. 431-446